annual total liabilities:
$144.50M+$21.53M(+17.51%)Summary
- As of today (June 28, 2025), DNLI annual total liabilities is $144.50 million, with the most recent change of +$21.53 million (+17.51%) on December 31, 2024.
- During the last 3 years, DNLI annual total liabilities has fallen by -$297.38 million (-67.30%).
- DNLI annual total liabilities is now -68.16% below its all-time high of $453.75 million, reached on December 31, 2020.
Performance
DNLI Total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly total liabilities:
$148.66M+$4.16M(+2.88%)Summary
- As of today (June 28, 2025), DNLI quarterly total liabilities is $148.66 million, with the most recent change of +$4.16 million (+2.88%) on March 31, 2025.
- Over the past year, DNLI quarterly total liabilities has increased by +$23.04 million (+18.34%).
- DNLI quarterly total liabilities is now -67.24% below its all-time high of $453.75 million, reached on December 31, 2020.
Performance
DNLI quarterly total liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DNLI Total liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +17.5% | +18.3% |
| 3 y3 years | -67.3% | -63.1% |
| 5 y5 years | -8.7% | -1.3% |
DNLI Total liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.3% | +17.5% | -66.4% | +28.7% |
| 5 y | 5-year | -68.2% | +17.5% | -67.2% | +28.7% |
| alltime | all time | -68.2% | +590.5% | -67.2% | +765.7% |
DNLI Total liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $148.66M(+2.9%) |
| Dec 2024 | $144.50M(+17.5%) | $144.50M(+6.6%) |
| Sep 2024 | - | $135.52M(+17.3%) |
| Jun 2024 | - | $115.51M(-8.0%) |
| Mar 2024 | - | $125.62M(+2.2%) |
| Dec 2023 | $122.96M(-70.6%) | $122.96M(+3.8%) |
| Sep 2023 | - | $118.45M(-0.4%) |
| Jun 2023 | - | $118.91M(-73.1%) |
| Mar 2023 | - | $442.64M(+5.9%) |
| Dec 2022 | $417.81M(-5.4%) | $417.81M(+0.4%) |
| Sep 2022 | - | $416.30M(+2.0%) |
| Jun 2022 | - | $408.01M(+1.3%) |
| Mar 2022 | - | $402.93M(-8.8%) |
| Dec 2021 | $441.87M | $441.87M(+1.0%) |
| Sep 2021 | - | $437.69M(+0.1%) |
| Jun 2021 | - | $437.11M(-1.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $442.50M(-2.5%) |
| Dec 2020 | $453.75M(+186.6%) | $453.75M(+141.7%) |
| Sep 2020 | - | $187.76M(+29.3%) |
| Jun 2020 | - | $145.17M(-3.6%) |
| Mar 2020 | - | $150.55M(-4.9%) |
| Dec 2019 | $158.34M(+37.5%) | $158.34M(-3.9%) |
| Sep 2019 | - | $164.78M(+1.4%) |
| Jun 2019 | - | $162.43M(+1.6%) |
| Mar 2019 | - | $159.95M(+38.9%) |
| Dec 2018 | $115.14M(+450.2%) | $115.14M(+38.2%) |
| Sep 2018 | - | $83.30M(+1.9%) |
| Jun 2018 | - | $81.78M(+9.2%) |
| Mar 2018 | - | $74.92M(+258.1%) |
| Dec 2017 | $20.93M(-94.3%) | $20.93M(+21.9%) |
| Sep 2017 | - | $17.17M(-95.3%) |
| Dec 2016 | $365.22M(+598.1%) | $365.22M |
| Dec 2015 | $52.32M | - |
FAQ
- What is Denali Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Denali Therapeutics?
- What is Denali Therapeutics annual total liabilities year-on-year change?
- What is Denali Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Denali Therapeutics?
- What is Denali Therapeutics quarterly total liabilities year-on-year change?
What is Denali Therapeutics annual total liabilities?
The current annual total liabilities of DNLI is $144.50M
What is the all time high annual total liabilities for Denali Therapeutics?
Denali Therapeutics all-time high annual total liabilities is $453.75M
What is Denali Therapeutics annual total liabilities year-on-year change?
Over the past year, DNLI annual total liabilities has changed by +$21.53M (+17.51%)
What is Denali Therapeutics quarterly total liabilities?
The current quarterly total liabilities of DNLI is $148.66M
What is the all time high quarterly total liabilities for Denali Therapeutics?
Denali Therapeutics all-time high quarterly total liabilities is $453.75M
What is Denali Therapeutics quarterly total liabilities year-on-year change?
Over the past year, DNLI quarterly total liabilities has changed by +$23.04M (+18.34%)